دورية أكاديمية

695P Drug-drug interactions between pazopanib and proton pump inhibitors may significantly affect clinical outcome of patients affected by metastatic renal cell carcinoma

التفاصيل البيبلوغرافية
العنوان: 695P Drug-drug interactions between pazopanib and proton pump inhibitors may significantly affect clinical outcome of patients affected by metastatic renal cell carcinoma
المؤلفون: Del Re, M., Brighi, N., Rizzo, M., Paolieri, F., Rebuzzi, S.E., Beninato, T., Crucitta, S., Mercinelli, C., Gri, N., Puglisi, S., Verzoni, E., Bleve, S., Cucchiara, F., Procopio, G., Fornarini, G., Galli, L., Porta, C.G., De Giorgi, U., Danesi, R.
المصدر: In Annals of Oncology September 2021 32 Supplement 5:S709-S709
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2021.08.091